Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

GlaxoSmithKline, GSK head office, GSK, UK

Could a lack of healthcare investment threaten the UK's status as a life sciences leader? Image courtesy of GlaxoSmithKline.

cachename:Featurescachekey:rd287061521_358764678_rd221744618_-384231710_rd-1665407042_727740091_rd-488908060_1008847663_